Expression of FGF23/KLOTHO system in human vascular tissue-Reference-Cited by-同舟云学术

Expression of FGF23/KLOTHO system in human vascular tissue

Published:2013-04 Issue:1 Volume:165 Page:179-183
ISSN:0167-5273
Container-title:International Journal of Cardiology
language:en
Short-container-title:International Journal of Cardiology

Author:

Donate-Correa Javier,Mora-Fernández Carmen,Martínez-Sanz Rafael,Muros-de-Fuentes Mercedes,Pérez Horacio,Meneses-Pérez Beatriz,Cazaña-Pérez Violeta,Navarro-González Juan F.

Funder

Fondo de Investigación Sanitaria, Instituto de Salud Carlos III, Ministerio de Sanidad y Consumo

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference37 articles.

1. FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting;Riminucci;J Clin Invest,2003

2. Overview of the FGF23–Klotho axis;Kuro-o;Pediatr Nephrol,2010

3. Identification of a novel fibroblast growth factor, FGF-23, preferentially expressed in the ventrolateral thalamic nucleus of the brain;Yamashita;Biochem Biophys Res Commun,2000

4. Analysis of the biochemical mechanisms for the endocrine actions of fibroblast growth factor-23;Yu;Endocrinology,2005

5. Klotho and aging;Kuro-o;Biochim Biophys Acta,2009

Cited by 91 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Local vascular Klotho mediates diabetes-induced atherosclerosis via ERK1/2 and PI3-kinase-dependent signaling pathways;Atherosclerosis;2024-09

2. Pentoxifylline ameliorates subclinical atherosclerosis progression in patients with type 2 diabetes and chronic kidney disease: a randomized pilot trial;Cardiovascular Diabetology;2024-08-24

3. Pentoxifylline Ameliorates Subclinical Atherosclerosis Progression in Patients with Type 2 Diabetes and Chronic Kidney Disease: A Randomized Pilot Trial;2024-07-03

4. Role of klotho and fibroblast growth factor 23 in arterial calcification, thickness, and stiffness: a meta-analysis of observational studies;Scientific Reports;2024-03-08

5. Soluble Klotho, a Potential Biomarker of Chronic Kidney Disease–Mineral Bone Disorders Involved in Healthy Ageing: Lights and Shadows;International Journal of Molecular Sciences;2024-02-03